If you are wondering whether Medpace Holdings is still worth buying after its huge run, or if most of the upside is already priced in, you are not alone. The stock has climbed 70.8% year to date and ...
For this year, Medpace expects that its revenues will increase by 17.1%, which is an excellent growth rate. From 2019 to Q2 2025, Medpace's outstanding common shares declined by 22.16%, creating value ...
Medpace has had an excellent financial performance. Its revenues increased by 495.26% between 2016Q2 and 2024Q3. Meanwhile, its current ROE is 54.08%. The company focused on small and mid-size ...
If you are wondering whether Medpace Holdings at around $548 a share is still worth considering after its huge run, or if you are late to the party, you are in the right place. Despite a sharp ...
In the latest quarter, 9 analysts provided ratings for Medpace Hldgs (NASDAQ:MEDP), showcasing a mix of bullish and bearish perspectives. In the table below, you'll find a summary of their recent ...
CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the third quarter ended September 30, 2024. Third Quarter 2024 Financial Results ...
The latest price target for Medpace Hldgs (NASDAQ:MEDP) was reported by BMO Capital on November 13, 2025. The analyst firm set a price target for $600.00 expecting MEDP to rise to within 12 months (a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results